Alnylam Advances RNAi Therapeutics Pipeline and Files Company's First Systemic Delivery IND

December 23, 2008

Alnylam Publishes Pre-Clinical Research on Direct CNS Delivery of RNAi Therapeutics

December 19, 2008

athenahealth Assumes Top National Ranking in 2008 KLAS Practice Management Category for Small Physician Practices

December 17, 2008

Momenta Pharmaceuticals to Raise $24.1 Million Through Registered Direct Offering

December 12, 2008

Alnylam Pharmaceuticals and Roche Collaboration Selected as Best Partnership Alliance by Scrip

December 11, 2008

Alnylam Provides Update on Kreutzer-Limmer Patent Family

December 09, 2008

Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin

December 08, 2008

Alnylam Strengthens Intellectual Property Estate through Acquisition of Nucleonics Patent Assets

December 08, 2008

Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum

December 04, 2008

Cubist Pharmaceuticals Names Santosh J. Vetticaden as Senior Vice President, Clinical Development and Chief Medical Officer

December 02, 2008

Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever

November 30, 2008

Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program

November 20, 2008

athenahealth to Host First Annual Investor Summit

November 19, 2008

IMM, Cenix, and Alnylam Discover New Targets in Malaria Infection with RNAi Technology

November 11, 2008

USDA Awards $1.5 Million to Expand Access to High-Quality Critical Care in Rural Communities

November 11, 2008

The Boston Globe names Cubist to Globe 100's Top Places to Work '08

November 10, 2008

Regulus Therapeutics and Collaborators Discover Role of a microRNA in Tumor Angiogenesis

November 06, 2008

athenahealth, Inc. Reports Third Quarter 2008 Results

November 06, 2008

Alnylam Pharmaceuticals Reports Third Quarter 2008 Financial Results

November 05, 2008

Alnylam and Collaborators Publish New Pre-clinical Research on Therapeutic Silencing of Key Gene Implicated in Parkinson's Disease

November 04, 2008

Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms

November 03, 2008

Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2008

November 03, 2008

Rib-X C.E.O. Susan Froshauer, Ph.D., Honored by The Connecticut Women's Hall of Fame

October 31, 2008

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC / IDSA Joint Meeting

October 26, 2008

CUBICIN(R) Outcomes Registry and Experience (CORE(R)) Marks Milestone

October 21, 2008

Medical Practices Maximize Incentive Payments Using athenahealth's National Physician Network for the Physician Quality Reporting Initiative

October 20, 2008

Sirtris CEO Christoph Westphal Selected by Biotech CEOs as Outstanding Individual

October 16, 2008

Cubist Pharmaceuticals Q3 2008 Revenues up 41%; Net Income up 39%: Total Revenues $112.4 Million; CUBICIN(R) Net Product Revenues $110.6 Million

October 16, 2008

Alnylam Scientists Present Data from Multiple Programs at the 4th Annual Meeting of the Oligonucleotide Therapeutics Society

October 15, 2008

athenahealth Chief Operating Officer and Executive Vice President Retires Due to Health Reasons

October 08, 2008

Alnylam Earns $20 Million Payment from Takeda

October 07, 2008

Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer

October 01, 2008

Sirtris’ Review of Sirtuin Therapeutics for Diseases of Aging in the Journal Nature Reviews Drug Discovery

October 01, 2008

Cubist Pharmaceuticals Opens New Research Facility at Lexington Headquarters

September 29, 2008

OrthoArkansas Joins Growing List of Leading Orthopedic Groups Leveraging athenahealth's National Physician Network and On-Demand Services

September 16, 2008

Sirtris Completes Exclusive License to Harvard's SIRT3-Based Intellectual Property

September 16, 2008

Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Pharmaceuticals Discover New Pathway for Malaria Infection

September 11, 2008

athenahealth Completes Acquisition of MedicalMessaging.net Assets

September 08, 2008

Cubist Pharmaceuticals Provides Update on Advancing Product Pipeline

September 08, 2008

Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board

September 08, 2008

Suncoast Medical Clinic Selects athenahealth's On-Demand Practice Management and Billing Service

September 04, 2008

Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors

September 03, 2008

Cubist Pharmaceuticals to Host Investor Event: Act 2 - Raising the Curtain on Cubist's Pipeline

September 02, 2008

Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors

September 02, 2008

Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors

August 19, 2008

Presbyterian Anesthesia Associates Goes Live on athenahealth's Software-Enabled Service, athenaCollector(SM)

August 15, 2008

Alnylam and Collaborators Publish New Pre-Clinical Research on RNAi-Mediated Silencing of PCSK9, a Genetically Validated Regulator of LDL Metabolism

August 12, 2008

Alnylam Forms Collaboration with Max Planck Institute to Investigate Biological Mechanisms for Cellular Uptake of RNAi Therapeutics

August 11, 2008

Alnylam Awarded Continued Funding Under U.S. Government Contract to Develop RNAi Therapeutics for Biological Threats

August 06, 2008

athenahealth to Acquire MedicalMessaging.net Assets, Gaining New Patient Communications Service Capabilities

August 04, 2008

Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

August 04, 2008

Rib-X Pharmaceuticals, Inc. Appoints Dr. George Milne as Executive Chairman of the Board of Directors

July 31, 2008

RediClinic to Leverage athenahealth's EMR and Practice Management Services for its National Retail Clinic Network

July 30, 2008

Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection

July 29, 2008

Momenta Pharmaceuticals Announces Results from M118 Drug-Drug Interaction Study with Aspirin and Clopidogrel

July 28, 2008

Intellectual Property License to Calando for Development and Commercialization of RNAi Therapeutics

July 21, 2008

Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis

July 16, 2008

RIB-X PHARMACEUTICALS INITIATES PHASE 2 TRIAL FOR RX-3341 IN COMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS

July 15, 2008

Long-Term Study of Middle-Aged Mice Shows Resveratrol Improves Health and Mimics Some Benefits of Dietary Restriction

July 03, 2008

Cubist to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.

July 02, 2008

Cubist to Announce 2Q08 Financial Results on July 17, 2008

July 01, 2008

Cubist Testifies on Need to Encourage Antibiotic Research and Development

June 24, 2008

Cubist Appoints Mark H.N. Corrigan, M.D., to its Board of Directors

June 24, 2008

athenahealth Appoints New General Counsel

June 19, 2008

Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia

June 19, 2008

Cubist Appoints Nancy J. Hutson, Ph.D., to its Board of Directors

June 16, 2008

Wayne State University Physician Group Selects athenahealth's Centrally-Hosted Practice Management Services

June 05, 2008

GLAXOSMITHKLINE SUCCESSFULLY COMPLETES TENDER OFFER FOR SHARES OF SIRTRIS PHARMACEUTICALS

June 02, 2008

Aetna Ranks First in 2008 PayerView(SM) Ranking; Pays Medical Providers the Fastest Among National Commercial Insurers

May 29, 2008

athenahealth to Release 2008 PayerView(SM) Rankings

May 28, 2008

Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics

May 27, 2008

Alnylam and Collaborators Publish In Vivo Research on Validation of a Mammalian Host Gene Involved in Malaria Infection and on the Anti-Parasitic Efficacy of RNAi Therapeutics

May 13, 2008

Alnylam Pharmaceuticals Reports First Quarter 2008 Financial Results

May 08, 2008

Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008

May 07, 2008

Thomson Reuters and Lance Armstrong Foundation Provide Online Cancer Information

May 06, 2008

athenahealth, Inc. Reports First-Quarter 2008 Results

May 06, 2008

Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs

May 06, 2008

Regulus Therapeutics Exclusively Licenses Intellectual Property from Stanford University Relating to microRNA Antagonists to Treat Inflammatory Diseases

May 06, 2008

Connecticut State Medical Society Joins with athenahealth to Offer On-Demand Practice Management Services to Physicians Statewide

May 02, 2008

GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals

May 02, 2008

Sirtris Pharmaceuticals Reports First Quarter 2008 Financial Results

May 01, 2008

Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA

April 29, 2008

GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development

April 22, 2008

Alnylam Initiates Phase II Trial to Evaluate Safety and Tolerability of ALN-RSV01 in Adult Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus (RSV) Infection

April 09, 2008

athenahealth, Inc. Reports Fourth-Quarter and Full-Year 2007 Results

March 05, 2008

Sirtris Pharmaceuticals' SRT501 Slows Retinal Ganglion Cell Loss During Optic Neuritis in a Preclinical Model of Multiple Sclerosis

March 04, 2008

Thomson Healthcare Cancer Profiler used in study

March 03, 2008

athenahealth Awarded Community Health Systems Contract

February 27, 2008

Sirtris Pharmaceuticals Reports Fourth Quarter and 2007 Financial Results; Significant Progress Achieved

February 25, 2008

Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2007

February 14, 2008

Leonard P. Guarente, a Founder of the Sirtuin Field, Signs Exclusive Consulting Agreement with Sirtris Pharmaceuticals

February 05, 2008

Thomson Healthcare online treatment tools mark milestone

February 02, 2008

athenahealth's National Physician Network Live With New Centers for Medicare and Medicaid Services Pay-For-Performance Measures

January 29, 2008

Alnylam Announces Grant of New Patent Covering RNAi Therapeutics in the United Kingdom

January 28, 2008

Cubist Pharmaceuticals Reports GAAP Diluted Net Income of $0.16 Per Share in Fourth Quarter 2007 and GAAP Diluted Net Income of $0.85 Per Share for Full Year 2007

January 23, 2008

AccentCare Newport Beach Ranked Among the Top 25 Percent of Home Health Providers in the Country for 2007

January 23, 2008

Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741

January 04, 2008